Ultrasound targeted microbubble destruction for drug and gene delivery

Expert Opinion on Drug Delivery

Volumn 5, Issue 10, 2008, Pages 1121-1138

  Mayer, Christian R ^a   Geis, Nicolas A ^a   Katus, Hugo A ^a   Bekeredjian, Raffi ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Drug delivery; Gene therapy; Microbubble; Sonoporation; Ultrasound

Indexed keywords

ALBUMIN; BETA GALACTOSIDE; BETACELLULIN; BLEOMYCIN; CAMPTOTHECIN; CHLORAMPHENICOL ACETYLTRANSFERASE; COPOLYMER; DOXORUBICIN; GREEN FLUORESCENT PROTEIN; LIPID; LIPOPLEX; LIPOSOME; LUCIFERASE; METHOTREXATE; PACLITAXEL; PERFLUTREN; PHOSPHOLIPID; PLASMID DNA; PROTEIN P53; RESVERATROL; SCATTER FACTOR; SMAD7 PROTEIN; SMALL INTERFERING RNA; SONOVUE; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR PDX 1; UNINDEXED DRUG; VASCULOTROPIN; VIRUS VECTOR;

ARTERY INTIMA PROLIFERATION; ARTHRITIS; BLOOD BRAIN BARRIER; BRAIN TUMOR; BREAST CANCER; CARDIOMYOPATHY; DIABETES MELLITUS; DRUG CAPSULE; DRUG COATING; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; EYELID TUMOR; GENE DELIVERY SYSTEM; GENE SILENCING; GENE TARGETING; GENE TRANSFER; GENE VECTOR; GRAFT FAILURE; HEART FAILURE; HEART INFARCTION; LIPOSOMAL DELIVERY; MICROBUBBLE; MICROENCAPSULATION; MUSCLE ISCHEMIA; NANOPHARMACEUTICS; NON INVASIVE PROCEDURE; NONHUMAN; PROTEIN TRANSPORT; REPORTER GENE; REVIEW; ULTRASOUND;

ANIMALS; DRUG DELIVERY SYSTEMS; GENE SILENCING; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; INJECTIONS, INTRAVENOUS; MICROBUBBLES; ULTRASONICS;

EID: 55149089888     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.5.10.1121     Document Type: Review

References (129)

1. Tei C, Sakamaki T, Shah PM, et al. Myocardial contrast echocardiography: a reproducible technique of myocardial opacification for identifying regional perfusion deficits. Circulation 1983;67:585-93
2. Kuznetsova LA, Khanna S, Amso NN, et al. Cavitation bubble-driven cell and particle behavior in an ultrasound standing wave. J Acoust Soc Am 2005;117:104-12:
3. Dollet B, van der Meer SM, Garbin V, et al. Nonspherical oscillations of ultrasound contrast agent microbubbles. Ultrasound Med Biol 2008;34:1465-73
4. Church CC, Allen JS. Mathematical models for contrast bubble dynamics. J Acoust Soc Am 2008;123:3111
5. Dalecki D; WFUMB Safety Symposium on Echo-Contrast Agents. bioeffects of ultrasound contrast agents in vivo. Ultrasound Med Biol 2007;33:205-13
6. Bull JL. The application of microbubbles for targeted drug delivery. Expert Opin Drug Deliv 2007;4:475-93
7. Klibanov AL. Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications. Invest Radiol 2006;41:3544-62
8. Postema M, Schmitz G. Ultrasonic bubbles in medicine: influence of the shell. Ultrason Sonochem 2007;14:438-44
9. Fang JY, Hung CF, Liao MH, et al. A study of the formulation design of acoustically active lipospheres as carriers for drug delivery. Eur J Pharm Biopharm 2007;67:67-75
10. May DJ, Allen JS, Ferrara KW. Dynamics and fragmentation of thick-shelled microbubbles. IEEE Trans Ultrason Ferroelectr Freq Control 2002;49:140040
11. El-Sherif DM, Wheatley MA. Development of a novel method for synthesis of a polymeric ultrasound contrast agent. J Biomed Mater Res A 2003;66:347-55
12. Narayan P, Marchant D, Wheatley MA. Optimization of spray drying by factorial design for production of hollow microspheres for ultrasound imaging. J Biomed Mater Res 2001;56:333-41
13. Smith MD, Elion JL, McClure RR, et al. Left heart opacification with peripheral venous injection of a new saccharide echo contrast agent in dogs. J Am Coll Cardiol 1989;13:1622-8
14. Smith MD, Kwan OL, Reiser HJ, et al. Superior intensity and reproducibility of SHU-454, a new right heart contrast agent. J Am Coll Cardiol 1984;3:992-8
15. Feinstein SB, Cheirif J, Ten Cate FJ, et al. Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results. J Am Coll Cardiol 1990;16:316-24
16. Simon RH, Ho SY, D'Arrigo J, et al. Lipid-coated ultrastable microbubbles as a contrast agent in neurosonography. Invest Radiol 1990;25:1300-4
17. Schneider M, Broillet A, Bussat P, et al. Gray-scale liver enhancement in VX2 tumor-bearing rabbits using BR14, a new ultrasonographic contrast agent. Invest Radiol 1997;32:410-7
18. Meza M, Greener Y, Hunt R, et al. Myocardial contrast echocardiography: reliable, safe, and efficacious myocardial perfusion assessment after intravenous injections of a new echocardiographic contrast agent. Am Heart J 1996;132:871-81
19. Fritz TA, Unger EC, Sutherland G, et al. Phase I clinical trials of MRX-115. A new ultrasound contrast agent. Invest Radiol 1997;32:735-40
20. Porter TR, Xie F, Kricsfeld A, et al. Noninvasive identification of acute myocardial ischemia and reperfusion with contrast ultrasound using intravenous perfluoropropane-exposed sonicated dextrose albumin. J Am Coll Cardiol 1995;26:33-40
21. Forsberg F, Basude R, Liu JB, et al. Effect of filling gases on the backscatter from contrast microbubbles: theory and in vivo measurements. Ultrasound Med Biol 1999;25:1203-11
22. Pelura TJ. Clinical experience with AF0150 (Imagent US), a new ultrasound contrast agent. Acad Radiol 1998;5(Suppl 1):S69-71; discussion S72-4
23. Postema M, Bouakaz A, ten Cate FJ, et al. Nitric oxide delivery by ultrasonic cracking: some limitations. Ultrasonics 2006;44(Suppl 1):e 109-13
24. Korpanty G, Grayburn PA, Shohet RV, et al. Targeting vascular endothelium with avidin microbubbles. Ultrasound Med Biol 2005;31:1279-83
25. Frenkel PA, Chen S, Thai T, et al. DNA-loaded albumin microbubbles enhance ultrasound-mediated transfection in vitro. Ultrasound Med Biol 2002;28:817-22
26. Lentacker I, De Geest BG, Vandenbroucke RE, et al. Ultrasound-responsive polymer-coated microbubbles that bind and protect DNA. Langmuir 2006;22:7273-8
27. Ferrara K, Pollard R, Borden M. Ultrasound microbubble contrast agents: fundamentaLs and application to gene and drug delivery. Ann Rev Biomed Eng 2007;9:415-47
28. Bekeredjian R, Grayburn PA, Shohet RV. Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. J Am Coll Cardiol 2005;45:329-35
29. Huber PE, Pfisterer P. In vitro and in vivo transfection of plasmid DNA in the Dunning prostate tumor R3327-AT1 is enhanced by focused ultrasound. Gene Ther 2000;7:1516-25
30. Seemann S, Hauff P, Schultze-Mosgau M, et al. Pharmaceutical evaluation of gas-filled microparticles as gene delivery system. Pharm Res 2002;19:250-7
31. Lum AF, Borden MA, Dayton PA, et al. Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles. J Control Release 2006;111:128-34
32. Dufrene YBW, Green J, Lee G. Nanometerscale surface properties of mixed phopholipid monolayers and bilayers. Langmuir 1997;1:370-7
33. Mehier-Humbert S, Yan F, Frinking P, et al. Ultrasound-mediated gene delivery: influence of contrast agent on transfection. Bioconjug Chem 2007;18:652-62
34. Available from: http://www.ncbi.nlm.nih.gov/books/bookres.fcgi/micad/ home.html
35. Unger EC, McCreery TP, Sweitzer RH, et al. Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent. Invest Radiol 1998;33:886-92
36. Borden MA, Caskey CF, Little E, et al. DNA and polylysine adsorption and multilayer construction onto cationic lipid-coated microbubbles. Langmuir 2007;23:9401-8
37. Muller OJ, Katus HA, Bekeredjian R. Targeting the heart with gene therapy-optimized gene delivery methods. Cardiovasc Res 2007;73:453-62
38. Dayton PA, Rychak JJ. Molecular ultrasound imaging using microbubble contrast agents. Front Biosci 2007;12:5124-42
39. Lindner JR, Coggins MP, Kaul S, et al. Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin- and complement-mediated adherence to activated leukocytes. Circulation 2000;101:668-75
40. Lindner JR, Dayton PA, Coggins MP, et al. Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. Circulation 2000;102:531-8
41. Lindner JR, Song J, Xu F, et al. Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation 2000;102:2745-50
42. Christiansen JP, Leong-Poi H, Klibanov AL, et al. Noninvasive imaging of myocardial reperfusion injury using leukocyte-targeted contrast echocardiography. Circulation 2002;105:1764-67
43. Klibanov AL, Hughes MS, Villanueva FS, et al. Targeting and ultrasound imaging of microbubble-based contrast agents. Magma 1999;8:177-84
44. Borden MA, Sarancos MR, Stieger SM, et al. Ultrasound radiation force modulates ligand availability on targeted contrast agents. Mol Imaging 2006;5:139-47
45. Rovai D, Lombardi M, Cini G, et al. Echocardiographic contrast imaging of the human right heart: a multicenter study of the efficacy, safety, and reproducibility of intravenous SHU-454. J Clin Ultrasound 1991;19:523-30
46. Miller DL, Gies RA. Gas-body-based contrast agent enhances vascular bioeffects of 1.09 MHz ultrasound on mouse intestine. Ultrasound Med Biol 1998;24:1201-8
47. Miller DL, Gies RA. The influence of ultrasound frequency and gas-body composition on the contrast agent-mediated enhancement of vascular bioeffects in mouse intestine. Ultrasound Med Biol 2000;26:307-13
48. Miller DL, Quddus J. Diagnostic ultrasound activation of contrast agent gas bodies induces capillary rupture in mice. Proc Natl Acad Sci USA 2000;97:10179-84
49. Dalecki D, Raeman CH, Child SZ, et al. The influence of contrast agents on hemorrhage produced by lithotripter fields. Ultrasound Med Biol 1997;23:1435-9
50. Dalecki D, Raeman CH, Child SZ, et al. Hemolysis in vivo from exposure to pulsed ultrasound. Ultrasound Med Biol 1997;23:307-13
51. Meairs S, Alonso A. Ultrasound, microbubbles and the blood-brain barrier. Prog Biophys Mol Biol 2007;93:354-62
52. Kobayashi N, Yasu T, Yamada S, et al. Endothelial cell injury in venule and capillary induced by contrast ultrasonography. Ultrasound Med Biol 2002;28:949-56
53. Shohet RV, Chen S, Zhou YT, et al. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation 2000;101:2554-6
54. Lawrie A, Brisken AF, Francis SE, et al. Microbubble-enhanced ultrasound for vascular gene delivery. Gene Ther 2000;7:2023-7
55. Taniyama Y, Tachibana K, Hiraoka K, et al. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther 2002;9:372-80
56. Kondo I, Ohmori K, Oshita A, et al. Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: the first demonstration of myocardial transfer of a 'functional' gene using ultrasonic microbubble destruction. J Am Coll Cardiol 2004;44:644-53
57. Li X, Wang Z, Ran H, et al. Experimental research on therapeutic angiogenesis induced by hepatocyte growth factor directed by ultrasound-targeted microbubble destruction in rats. J Ultrasound Med 2008;27:453-60
58. Korpanty G, Chen S, Shohet RV, et al. Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles. Gene Ther 2005;12:1305-12
59. Zhigang W, Zhiyu L, Haitao R, et al. Ultrasound-mediated microbubble destruction enhances VEGF gene delivery to the infarcted myocardium in rats. Clin Imaging 2004;28:395-8
60. Leong-Poi H, Kuliszewski MA, Lekas M, et al. Therapeutic arteriogenesis by ultrasound-mediated VEGF 165 plasmid gene delivety to chronically ischemic skeletal muscle. Circ Res 2007;101:295-303
61. Hashiya N, Aoki M, Tachibana K, et al. Local delivery of E2F decoy oligodeoxynudeotides using ultrasound with microbubble agent (Optison) inhibits intimal hyperplasia after balloon injury in rat casotid artery model. Biochem Biophys Res Commun 2004;317:508-14
62. Kipshidze NN, Porter TR, Dangas G, et al. Systemic targeted delivery of antisense with perflourobutane gas microbubble carrier reduced neointimal formation in the porcine coronary restenosis model. Cardiovasc Radiat Med 2003;4:152-9
63. Taniyama Y, Tachibana K, Hiraoka K, et al. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 2002;105:1233-9
64. Zen K, Okigaki M, Hosokawa Y, et al. Myocardium-targeted delivery of endothelial progenitor cells by ultrasound-mediated microbubble destruction improves cardiac function via an angiogenic response. J Mol Cell Cardiol 2006;40:799-809
65. Iwasaki M, Adachi Y, Nishiue T, et al. Hepatocyte growth factor delivered by ultrasound-mediated destruction of microbubbles induces proliferation of cardiomyocytes and amelioration of left ventricular contractile function in Doxorubicin-induced cardiomyopathy. Stem Cells 2005;23:1589-97
66. Mukherjee D, Wong J, Griffin B, et al. Ten-fold augmentation of endothelial uptake of vascular endothelial growth factor with ultrasound after systemic administration. J Am Coll Cardiol 2000;35:1678-86
67. Bekeredjian R, Chen S, Grayburn PA, et al. Augmentation of cardiac protein delivery using ultrasound targeted microbubble destruction. Ultrasound Med Biol 2005;31:687-91
68. Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2005;2:3-14
69. Lossinsky AS, Vorbrodt AW, Wisniewski HM. Scanning and transmission electron microscopic studies of microvascular pathology in the osmotically impaired blood-brain barrier. J Neurocytol 1995;24:795-806
70. Pan GY, Liu XD, Liu GQ. Intracarotid infusion of hypertonic mannitol changes permeability of blood-brain barrier to methotrexate in rats. Acta Pharmacol Sin 2000;21:613-6
71. Abbott NJ. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol 2000;20:131-47
72. Nomura T, Inamura T, Black KL. Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors. Brain Res 1994;659:62-6
73. Inamura T, Nomura T, Bartus RT, et al. Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors. J Neurosurg 1994;81:752-8
74. Droste DW. Clinical utility of contrast-enhanced ultrasound in neurosonology. Eur Neurol 2008;59(Suppl 1):2-8
75. Vykhodtseva NI, Hynynen K, Damianou C. Histologic effects of high intensity pulsed ultrasound exposure with subharmonic emission in rabbit brain in vivo. Ultrasound Med Biol 1995;21:969-79
76. Hynynen K, McDannold N, Vykhodtseva N, et al. Noninvasive MR imaging-guided focal opening of the blood-brain barrier: in rabbits. Radiology 2001;220:640-6
77. Hynynen K, McDannold N, Vykhodtseva N, et al. Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery. J Neurosurg 2006;105:445-54
78. McDannold N, Vykhodtseva N, Hynynen K. Effects of acoustic parameters and ultrasound contrast agent dose on focused-ultrasound induced blood-brain barrier disruption. Ultrasound Med Biol 2008;34:930-7
79. McDannold N, Vykhodtseva N, Hynynen K. Blood-brain barrier disruption induced by focused ultrasound and circulating preformed microbubbles appears to be characterized by the mechanical index. Ultrasound Med Biol 2008;34:834-40
80. Hynynen K, McDannold N, Sheikov NA, et al. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage 2005;24:12-20
81. Kinoshita M, McDannold N, Jolesz FA, et al. Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound. Biochem Biophys Res Commun 2006;340:1085-90**82 Sheikov N, McDannold N, Vykhodtseva N, et al. Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles. Ultrasound Med Biol 2004;30:979-89
82. Hynynen K, McDannold N, Vykhodtseva N, et al. Non-invasive opening of BBB by focused ultrasound. Acta Neurochir Suppl 2003;86:555-8
83. Treat LH, McDannold N, Vykhodtseva N, et al. Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRL-guided focused ultrasound. Int J Cancer 2007;121:901-7
84. Yang FY, Fu WM, Yang RS, et al. Quantitative evaluation of focused ultrasound with a contrast agent on blood-brain barrier disruption. Ultrasound Med Biol 2007;33:1421-7
85. Choi JJ, Pernot M, Brown TR, et al. Spatio-temporal analysis of molecular delivery through the blood-brain barrier using focused ultrasound. Phys Med Biol 2007;52:5509-30
86. Choi JJ, Pernot M, Small SA, et al. Noninvasive, transcranial and localized opening of the blood-brain barrier using focused ultrasound in mice. Ultrasound Med Biol 2007;33:9-104
87. Song J, Chappell JC, Qi M, et al. Influence of injection site, microvascular pressure and ultrasound variables on microbubble-mediated delivery of microspheres to muscle. J Am Coll Cardiol 2002;39:726-31
88. Price RJ, Skyba DM, Kaul S, et al. Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation 1998;98:1264-7
89. Iwanaga K, Tominaga K, Yamamoto K, et al. Local delivery system of cytotoxic agents to tumors by focused sonoporation. Cancer Gene Ther 2007;14:354-63
90. Shortencarier MJ, Dayton PA, Bloch SH, et al. A method for radiation-force localized drug delivery using gas-filled lipospheres. IEEE Trans Ultrason Ferroelectr Freq Control 2004;51:822-31
91. Ho SY, Barbarese E, D'Arrigo JS, et al. Evaluation of lipid-coated microbubbles as a delivery vehicle for Taxol in brain tumor therapy. Neurosurgery 1997;40:1260-6; discussion 1266-8
92. Tartis MS, McCallan J, Lum AF, et al. Therapeutic effects of paclitaxel-containing ultrasound contrast agents. Ultrasound Med Biol 2006;32:1771-80
93. Kheirolomoom A, Dayton PA, Lum AF, et al. Acoustically active microbubbles conjugated to liposomes: characterization of a proposed drug delivery vehicle. J Control Release 2007;118:275-84
94. Shive MS, Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 1997;28:5-24
95. Rapoport N, Gao Z, Kennedy A. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J Natl Cancer Inst 2007;99:1095-106
96. Gao Z, Kennedy AM, Christensen DA, et al. Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy. Ultrasonics 2007;48:260-70
97. Gao Z, Fain HD, Rapoport N. Ultrasound-enhanced tumor targeting of polymeric micellar drug carriers. Mol Pharm 2004;1:317-30
98. Li YS, Reid CN, McHale AP. Enhancing ultrasound-mediated cell membrane permeabilisation (sonoporation) using a high frequency pulse regime and implications for ultrasound-aided cancer chemotherapy. Cancer Lett 2008;266:156452
99. Bekeredjian R, Kroll RD, Fein E, et al. Ultrasound Targeted Microbubble Destruction Increases Capillary Permeability in Hepatomas. Ultrasound Med Biol 2007;33:1592-8
100. Stieger SM, Caskey CF, Adamson RH, et al. Enhancement of vascular permeability with low-frequency contrast-enhanced ultrasound in the chorioallantoic membrane model. Radiology 2007;243:112-21
101. Sonoda S, Tachibana K, Uchino E, et al. Inhibition of melanoma by ultrasound-microbubble-aided drug delivery suggests membrane permeabilization. Cancer Biol Ther 2007;6:1276-83
102. Shimamura M, Saro N, Taniyama Y, et al. Development of efficient plasmid DNA transfer into adult rat central nervous system using microbubble-enhanced ultrasound. Gene Ther 2004;11:1532-9
103. Shimamura M, Sato N, Taniyama Y, et al. Gene transfer into adult rat spinal com using naked plasmid DNA and ultrasound microbubbles. J Gene Med 2005;7:1468-74
104. Takahashi M, Kido K, Aoi A, et al. Spinal gene transfer using ultrasound and microbubbles. J Control Release 2007;117:267-72
105. Sonoda S, Tachibana K, Uchino E, et al. Gene transfer to corneal epithelium and keratocytes mediated by ultrasound with microbubbles. Invest Ophthalmol Vis Sci 2006;47:558-64
106. Yamashita T, Sonoda S, Suzuki R, et al. A novel bubble liposome and ultrasound-mediated gene transfer to ocular surface: RC-1 cells in vitro and conjunctiva in vivo. Exp Eye Res 2007;85:741-8
107. Shen ZP, Brayman AA, Chen L, et al. Ultrasound with microbubbles enhances gene expression of plasmid DNA in the liver via intraportal delivery. Gene Ther 2008;15:1147-55
108. Nishida K, Doita M, Takada T, et al. Sustained transgene expression in intervertebral disc cells in vivo mediated by microbubble-enhanced ultrasound gene therapy. Spine 2006;31:1415-9
109. Koike H, Tomita N, Azuma H, et al. An efficient gene transfer method mediated by ultrasound and microbubbles into the kidney. J Gene Med 2005;7:108-16
110. Guo H, Leung JC, Chan LY, et al. Ultrasound-contrast agent mediated naked gene delivery in the peritoneal cavity of adult rat. Gene Ther 2007;14:1712-20
111. Xenariou S, Griesenbach U, Liang HD, et al. Use of ultrasound to enhance nonviral lung gene transfer in vivo. Gene Ther 2007;14:768-74
112. Ka SM, Huang XR, Lan HY, et al. Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice. J Am Soc Nephrol 2007;18:1777-88
113. Chen S, Ding J, Yu C, et al. Reversal of streptozotocin-induced diabetes in rats by gene therapy with betacellulin and pancreatic duodenal homeobox-1. Gene Ther 2007;14:1102-10
114. Vannan M, McCreery T, Li P, et al. Ultrasound-mediated transfection of canine myocardium by intravenous administration of cadonic microbubble-linked plasmid DNA. J Am Soc Echocardiogr 2002;15:214-8
115. Teupe C, Richter S, Fisslthaler B, et al. Vascular gene transfer of phosphomimetic endothelial nitric oxide synthase (S1177D) using ultrasound-enhanced destruction of plasmid-loaded microbubbles improves vasoreactivity. Circulation 2002;105:1104-9
116. Chen S, Shohet RV, Bekeredjian R, et al. Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J Am Coll Cardiol 2003;42:30 1-8
117. Bekeredjian R, Chen S, Frenkel PA, et al. Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation 2003;108:1022-6
118. Pislaru SV, Pislaru C, Kinnick RR, et al. Optimization of ultrasound-mediated gene transfer: comparison of contrast agents and ultrasound modalities. Eur Heart J 2003;24:1690-8
119. Christiansen JP, French BA, Klibanov AL, et al. Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles. Ultrasound Med Biol 2003;29:1759-67
120. Li T, Tachibana K, Kuroki M. Gene transfer with echo-enhanced contrast agents: comparison between Albunex, Optison, and Levovist in mice - initial results. Radiology 2003;229:423-8
121. Lu QL, Liang HD, Partridge T, et al. Microbubble ultrasound improves the efficiency of gene transduction in skeletal muscle in vivo with reduced tissue damage. Gene Ther 2003;10:396-405
122. Erikson JM, Freeman GL, Chandrasekar B. Ultrasound-targeted antisense oligonucleotide attenuates ischemia/reperfusion-induced myocardial tumor necrosis factor-alpha. J Mol Cell Cardiol 2003;35:119-30
123. Guo DP, Li XY, Sun P, et al. Ultrasound/microbubble enhances foreign gene expression in ECV304 cells and murine myocardium. Acta Biochim Biophys Sin (Shanghai) 2004;36:824-31
124. Tsunoda S, Mazda O, Oda Y, et al. Sonoporation using microbubble BR14 promotes pDNA/siRNA transduction to murine heart. Biochem Biophys Res Commun 2005;336:118-27
125. Wang X, Liang HD, Dong B, et al. Gene transfer with microbubble ultrasound and plasmid DNA into skeleral muscle of mice: comparison between commercially available microbubble contrast agents. Radiology 2005;237:224-9
126. Akowuah EF, Gray C, Lawrie A, et al. Ultrasound-mediated delivery of TIMP-3 plasmid DNA into saphenous vein leads to increased lumen size in a porcine interposition graft model. Gene Ther 2005;12:1154-7
127. Nakaya H, Shimizu T, Isobe K, et al. Microbubble-enhanced ultrasound exposure promotes uptake of methotrexate into synovial cells and enhanced anti-inflammatory effects in the knees of rabbits with antigen-induced arthritis. Arthritis Rheum 2005;52:2559-66
128. Miao CH, Brayman AA, Loeb KR, et al. Ultrasound enhances gene delivery of human factor IX plasmid. Hum Gene Ther 2005;16:893-905
129. Aoi A, Watanabe Y, Mori S, et al. Herpes simplex virus thymidine kinase-mediated suicide gene therapy using nano/microbubbles and ultrasound. Ultrasound Med Biol 2008;34:425-34